Invasive disease due to group B Streptococcus infection (Streptococcus agalactiae) results
in a wide spectrum of clinical disease. In North America, serotypes Ia, Ib, II, III, and V are …

Since its emergence 25 years ago, group B streptococcus has become recognized as a
cause of serious illness in newborns, pregnant women, and adults with chronic medical …

Background. Early-onset group B streptococcal (GBS) prevention efforts are based on
targeted use of intrapartum antibiotic prophylaxis (IAP); applicability of these prevention …

During the 1990s the focus of group B streptococcus (GBS) disease research has shifted to
prevention. Increased use of intrapartum antimicrobial prophylaxis in North America and …

The population dynamics of Streptococcus agalactiae (group B streptococci [GBS])
colonization of the vagina and anorectal area was investigated in a cohort of 77 Danish …

Abstract Background: Group B streptococci (GBS), or Streptococcus agalactiae, are the
leading bacterial cause of meningitis and bacterial sepsis in newborns. Currently available …

Background: Intrapartum antibiotic prophylaxis for neonatal group B streptococcal disease
(GBS) effectively prevents disease among infants< 7 days old, but there are no prevention …

From 1993 through 1996, surveillance for invasive disease due to group B Streptococcus
(GBS) in neonates aged< 7 days and in peripartum pregnant women was performed in a …

Objectives. To define factors influencing vertical transmission of and neonatal colonization
with group B streptococci (GBS) in neonates representing ethnically and economically …

Background. Infant mortality in the United States has continued to decline in recent years,
but changes in sepsis-associated deaths among infants have not been evaluated …